JUNIPER PHARMACEUTICALS
Juniper Pharmaceuticals (Nasdaq: JNP) is developing therapeutics that address unmet medical needs in women’s health. Their current pipeline leverages the 505(b)(2) regulatory pathway with new formulations of existing pharmaceuticals. The Company has a successful history in developing pharmaceutical products, including Crinone® 8% (progesterone gel), which is commercially available in the United States and over 90 countries around the world. Their current intravaginal ring (IVR) product can... didates are: JNP-0101, an oxybutynin IVR for the treatment of overactive bladder in women; JNP-0201, a combination estrogen + progesterone IVR for menopausal symptoms; and, JNP-0301, a progesterone IVR for the prevention of preterm birth in women with a short cervical length at mid-pregnancy. They are leveraging the in-house pharmaceutical development, clinical trial supply manufacturing, and analytical capabilities of Juniper Pharma Services to advance an internal product pipeline, while also providing valuable intellectual property-related consultative services to their pharmaceutical industry customers. Juniper is positioned for success with a highly experienced leadership team in combination with a solid balance sheet and strong cash flows to advance a proprietary pipeline for long term value creation.
JUNIPER PHARMACEUTICALS
Industry:
Biotechnology Health Care
Founded:
1986-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.juniperpharma.com
Total Employee:
51+
Status:
Active
Contact:
+116176391500
Email Addresses:
[email protected]
Technology used in webpage:
Google Font API Domain Not Resolving Amazon GoDaddy DNS AWS Global Accelerator
Similar Organizations
Nora Therapeutics
Nora Therapeutics is a specialty biopharmaceutical company developing therapeutics to address clinical unmet needs in reproductive medicine.
Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.
Tavec pharma
Tavec Pharmaceuticals is developing injectable therapies to treat cancers.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2013-09-12 | Molecular Profiles | Molecular Profiles acquired by Juniper Pharmaceuticals | N/A |
Official Site Inspections
http://www.juniperpharma.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
